ARWR
Price
$16.81
Change
+$0.35 (+2.13%)
Updated
Jun 6 closing price
Capitalization
2.32B
63 days until earnings call
CGEN
Price
$1.74
Change
+$0.03 (+1.75%)
Updated
Jun 6 closing price
Capitalization
158.07M
52 days until earnings call
Interact to see
Advertisement

ARWR vs CGEN

Header iconARWR vs CGEN Comparison
Open Charts ARWR vs CGENBanner chart's image
Arrowhead Pharmaceuticals
Price$16.81
Change+$0.35 (+2.13%)
Volume$1.24M
Capitalization2.32B
Compugen
Price$1.74
Change+$0.03 (+1.75%)
Volume$232.3K
Capitalization158.07M
ARWR vs CGEN Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. CGEN commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Buy and CGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ARWR: $15.56 vs. CGEN: $1.45)
Brand notoriety: ARWR: Notable vs. CGEN: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 82% vs. CGEN: 88%
Market capitalization -- ARWR: $2.27B vs. CGEN: $147.56M
ARWR [@Biotechnology] is valued at $2.27B. CGEN’s [@Biotechnology] market capitalization is $147.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileCGEN’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • CGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, ARWR is a better buy in the long-term than CGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 5 TA indicator(s) are bullish while CGEN’s TA Score has 6 bullish TA indicator(s).

  • ARWR’s TA Score: 5 bullish, 4 bearish.
  • CGEN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, CGEN is a better buy in the short-term than ARWR.

Price Growth

ARWR (@Biotechnology) experienced а +1.63% price change this week, while CGEN (@Biotechnology) price change was +4.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

CGEN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.32B) has a higher market cap than CGEN($158M). CGEN YTD gains are higher at: -5.229 vs. ARWR (-17.234). CGEN has higher annual earnings (EBITDA): -14.41M vs. ARWR (-580.69M). ARWR has more cash in the bank: 553M vs. CGEN (103M). CGEN has less debt than ARWR: CGEN (2.91M) vs ARWR (525M). CGEN has higher revenues than ARWR: CGEN (27.9M) vs ARWR (2.5M).
ARWRCGENARWR / CGEN
Capitalization2.32B158M1,469%
EBITDA-580.69M-14.41M4,031%
Gain YTD-17.234-5.229330%
P/E RatioN/A60.33-
Revenue2.5M27.9M9%
Total Cash553M103M537%
Total Debt525M2.91M18,029%
FUNDAMENTALS RATINGS
ARWR vs CGEN: Fundamental Ratings
ARWR
CGEN
OUTLOOK RATING
1..100
2111
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
6382
P/E GROWTH RATING
1..100
227
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CGEN's Valuation (77) in the Biotechnology industry is in the same range as ARWR (94). This means that CGEN’s stock grew similarly to ARWR’s over the last 12 months.

CGEN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARWR (100). This means that CGEN’s stock grew similarly to ARWR’s over the last 12 months.

CGEN's SMR Rating (95) in the Biotechnology industry is in the same range as ARWR (100). This means that CGEN’s stock grew similarly to ARWR’s over the last 12 months.

ARWR's Price Growth Rating (63) in the Biotechnology industry is in the same range as CGEN (82). This means that ARWR’s stock grew similarly to CGEN’s over the last 12 months.

ARWR's P/E Growth Rating (2) in the Biotechnology industry is in the same range as CGEN (27). This means that ARWR’s stock grew similarly to CGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARWRCGEN
RSI
ODDS (%)
Bearish Trend 13 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 13 days ago
90%
Momentum
ODDS (%)
Bullish Trend 13 days ago
67%
Bullish Trend 13 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 13 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
83%
Bullish Trend 13 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
73%
Bearish Trend 13 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 25 days ago
81%
Declines
ODDS (%)
Bearish Trend about 1 month ago
84%
Bearish Trend about 1 month ago
89%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
82%
Bullish Trend 13 days ago
82%
Aroon
ODDS (%)
Bullish Trend 13 days ago
67%
Bullish Trend 13 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+1.24%
DNLI - ARWR
58%
Loosely correlated
-1.29%
NTLA - ARWR
57%
Loosely correlated
+3.59%
BEAM - ARWR
54%
Loosely correlated
-0.88%
RGNX - ARWR
54%
Loosely correlated
-5.84%
IMNM - ARWR
53%
Loosely correlated
+0.35%
More

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with BDTX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
+1.40%
BDTX - CGEN
39%
Loosely correlated
-2.93%
ROIV - CGEN
39%
Loosely correlated
-1.30%
ITOS - CGEN
37%
Loosely correlated
+17.94%
ARWR - CGEN
37%
Loosely correlated
+1.24%
RLAY - CGEN
37%
Loosely correlated
+3.51%
More